📰 Science Driven News
Science Driven News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Science Driven. Real-time updates on events, politics, business and more.
August 31, 2023
  COPENHAGEN, Denmark and HANGZHOU, China, August 31, 2023 / B3C newswire / -- MC2 Therapeutics, Ltd (“MC2”), a wholly owned subsidiary of MC2 Therapeutics A/S and Hangzhou Zhongmei Huadong Pharmaceutical Co (“Huadong”), a wholly owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), announced today a...
August 10, 2023
Arcutis to receive $30 million upfront payment and is eligible to receive potential development and commercial milestone payments, as well as double digit tiered royalties WESTLAKE VILLAGE, Calif. and HANGZHOU, China, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, and Hangzhou Zhongmei Huadong Pharmaceutical Co, a wholly owned subsidiary of Huad
August 10, 2023
Arcutis to receive $30 million upfront payment and is eligible to receive potential development and commercial milestone payments, as well as double digit...
August 5, 2023
UT Health Science Center chancellor: 'Our new strategic plan is our roadmap for a better future for the health of Tennessee.'
January 16, 2023
/PRNewswire/ -- CARsgen Therapeutics Holdings Limited (2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic...
November 16, 2022
MediBeacon approaching completion of Phase 3 study focused on kidney disease; Has submitted three of five required PMA modules needed for FDA approval ST. LOUIS, Nov. 16, 2022 /PRNewswire/
April 4, 2022
Growers often unknowingly limit yield potential with their nitrogen source choices. In cool conditions, not all nitrogen sources are available during this critical growth stage. The addition of soluble calcium during spring applications improves root growth and sets the crop up for improved yields this fall.
February 28, 2022
DGAP-News: Heidelberg Pharma AG / Key word(s): Alliance28.02.2022 / 07:04 The issuer is solely responsible for the content of this announcement.PRESS RELEASEHeidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment- Heidelberg Pharma grants Huadong exclusive license to develop and com...
February 28, 2022
Heidelberg Pharma grants Huadong exclusive license to develop and commercialize HDP-101 and HDP-103 in Asia [1] (excluding Japan), plus exclusive opt-in rights for two more pipeline candidates, with a
February 28, 2022
DGAP-News: Heidelberg Pharma AG / Key word(s): Alliance Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equit...